SOPHiA GENETICS SA Operating Margin 2020-2025 | SOPH
Current and historical operating margin for SOPHiA GENETICS SA (SOPH) over the last 10 years. The current operating profit margin for SOPHiA GENETICS SA as of March 31, 2025 is -98.51%.
| SOPHiA GENETICS SA Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-03-31 | $0.07B | $-0.06B | -92.65% |
| 2024-12-31 | $0.07B | $-0.07B | -100.00% |
| 2024-09-30 | $0.07B | $-0.07B | -104.62% |
| 2024-06-30 | $0.07B | $-0.07B | -107.69% |
| 2024-03-31 | $0.06B | $-0.08B | -117.19% |
| 2023-12-31 | $0.06B | $-0.08B | -120.97% |
| 2023-09-30 | $0.06B | $-0.07B | -122.41% |
| 2023-06-30 | $0.05B | $-0.08B | -144.44% |
| 2023-03-31 | $0.05B | $-0.08B | -160.78% |
| 2022-12-31 | $0.05B | $-0.09B | -183.33% |
| 2022-09-30 | $0.05B | $-0.09B | -204.35% |
| 2022-06-30 | $0.04B | $-0.09B | -206.82% |
| 2022-03-31 | $0.04B | $-0.08B | -197.62% |
| 2021-12-31 | $0.04B | $-0.07B | -180.00% |
| 2021-09-30 | $0.04B | $-0.06B | -167.57% |
| 2021-06-30 | $0.03B | $-0.05B | -147.06% |
| 2021-03-31 | $0.03B | $-0.04B | -136.67% |
| 2020-12-31 | $0.03B | $-0.04B | -132.14% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.217B | $0.065B |
| SOPHiA GENETICS SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM(TM) Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. SOPHiA GENETICS SA is based in BOSTON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.919B | 58.42 |
| Doximity (DOCS) | United States | $11.431B | 52.92 |
| Hims & Hers Health (HIMS) | United States | $10.838B | 112.61 |
| Tempus AI (TEM) | United States | $10.042B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.445B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.743B | 58.48 |
| Hinge Health (HNGE) | United States | $3.360B | 0.00 |
| Privia Health (PRVA) | United States | $2.603B | 177.92 |
| Enovis (ENOV) | United States | $1.886B | 10.52 |
| Phreesia (PHR) | United States | $1.689B | 0.00 |
| Schrodinger (SDGR) | United States | $1.514B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.471B | 0.00 |
| 10x Genomics (TXG) | United States | $1.468B | 0.00 |
| Azenta (AZTA) | United States | $1.439B | 66.87 |
| Evolent Health (EVH) | United States | $1.367B | 116.40 |
| Omnicell (OMCL) | United States | $1.355B | 23.90 |
| Claritev (CTEV) | United States | $0.794B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.587B | 0.00 |
| Veradigm (MDRX) | United States | $0.536B | 0.00 |
| Standard BioTools (LAB) | United States | $0.486B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.465B | 0.00 |
| Talkspace (TALK) | United States | $0.443B | 132.50 |
| Outset Medical (OM) | United States | $0.362B | 0.00 |
| TruBridge (TBRG) | United States | $0.340B | 754.67 |
| Health Catalyst (HCAT) | United States | $0.275B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.268B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.169B | 0.00 |
| American Well (AMWL) | United States | $0.127B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.124B | 0.00 |
| Pulmonx (LUNG) | United States | $0.106B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.101B | 0.00 |
| CareCloud (CCLD) | United States | $0.100B | 3.81 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.087B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.075B | 0.00 |
| 111 (YI) | China | $0.065B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.050B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.046B | 0.00 |
| HeartBeam (BEAT) | United States | $0.044B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |